Magi
AI to Disrupt Medical Imaging Device Regulation
Magi is a software that checks if medical images are suitable for clinical use, before doctors view them.
By acting as a regulatory middleware, Magi enables imaging hardware to completely skip regulatory approval processes, go straight to the clinical market, and be completely safe for medical use. Magi saves manufacturers tens of millions of dollars and years in development time.
Magi has the potential to massively transform medical imaging device markets. By accelerating device approvals, Magi could expand the current $1B digital pathology market to $100B in the USA, representing a staggering 10,000% market growth.
About Us
We are a team of doctors, scientists and engineers.
Aerin Cox
Co-Founder, Chief of Product
Aerin is a tech Product Manager previously in Healthcare and IT Infrastructure software companies, with a background in computer science and art.
Rajan Dewar MD PhD
Advisory Board
Dr. Rajan Dewar is a hematopathologist educated at Yale and Stanford medical school. He has been an advocate for Digital Pathology for many years.
Niraj Kapur
Advisory Board
With 23 years of experience, including positions at renowned biotech companies Genentech and Astellas, Niraj is a dynamic biotech commercial expert. He has a proven track record of driving business growth and forging strategic partnerships in the industry. Niraj's deep knowledge and expertise, coupled with his extensive background in sales, marketing, and account management, enable him to deliver tailored solutions in the hematology/oncology field, consistently achieving impactful results.
Samar Sayedyahossein MD PhD
Advisory Board
Dr. Sayedyahossein is a cancer biologist، A research scientist at the National Institutes of Health (NIH). She has over a decade of extensive experience specializing in molecular biology and advanced cell imaging technologies.
